Table 1 Demographic characteristics of COVID-19 patients without and with de novo bronchiectasis included in the study
From: Prevalence and early outcome of bronchiectasis as an atypical presentation in COVID-19 patients
COVID-19 without bronchiectasis (n = 400) | COVID-19 with de novo bronchiectasis (n = 14) | p | |
|---|---|---|---|
Age (years) | 52.62 ± 17.80 | 57.64 ± 10.96 | 0.30 |
Sex | 0.45 | ||
Male | 257 (64.3%) | 10 (71.4%) | |
Female | 143 (35.8%) | 4 (28.6%) | |
Active smoking | 323 (80.8%) | 5 (35.7%) | < 0.001 |
Comorbidities | |||
COPD | 26 (6.5%) | 6 (42.9%) | < 0.001 |
Bronchial asthma | 5 (1.3%) | 0 | 0.84 |
Diabetes mellitus | 76 (19%) | 2 (14.3%) | 0.49 |
Hypertension | 106 (26.5%) | 1 (7.1%) | 0.08 |
Hepatic disease | 2 (0.5%) | 0 | 0.93 |
Renal disease | 14 (3.5%) | 0 | 0.61 |
Cardiac diseases | 29 (7.2%) | 1 (7.1%) | 0.37 |
Other | 28 (7%) | 3 (21.4%) | 0.07 |